Literature DB >> 19486900

Carbohydrate deficient transferrin and forensic medicine.

Joris R Delanghe1, Marc L De Buyzere.   

Abstract

In forensic medicine, diagnosing chronic alcohol abuse is a difficult task. Carbohydrate deficient transferrin (CDT) is one of the most common diagnostic markers for detecting chronic alcohol abuse. However, its diagnostic value is not 100% sensitive and specific. A number of caveats are known (e.g. pre-analytical issues, mutant transferrins, some metabolic diseases, body composition, arterial hypertension, drug treatment, exposure to organic solvents). In view of the numerous caveats, a careful interpretation of CDT analysis is needed. For forensic and occupational medicine applications, such as delegation to working sites where alcoholism may have fatal consequences or to obtain a driver's license, a well-balanced interpretation is needed. For these purposes, high performance liquid chromatography or capillary zone electrophoresis are to be preferred for CDT analysis as their main advantage is the separation of different CDT isoforms. In problem cases, the use of additional alternative tests (e.g. ethyl glucuronide and fatty acid ethyl esters in hair) can be considered.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19486900     DOI: 10.1016/j.cca.2009.05.020

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

Review 1.  Postmortem chemistry update part II.

Authors:  Cristian Palmiere; Patrice Mangin
Journal:  Int J Legal Med       Date:  2011-10-09       Impact factor: 2.686

Review 2.  Alcoholic hepatitis 2010: a clinician's guide to diagnosis and therapy.

Authors:  Maziyar Amini; Bruce A Runyon
Journal:  World J Gastroenterol       Date:  2010-10-21       Impact factor: 5.742

3.  Carbohydrate-Deficient Transferrin Determination in a Clinical Setting: Consistency Between Capillary Electrophoresis Assays and Utility of HPLC as a Confirmatory Test.

Authors:  Agnese Veronesi; Cristina Rota; Tommaso Trenti; Elisabetta Cariani
Journal:  J Clin Lab Anal       Date:  2015-10-26       Impact factor: 2.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.